Skip to content

The effects of standard dose and fragmented exercise training on fatigue, sleep and quality of life during the postoperative radiotherapy period of breast cancer

The effects of standard dose and fragmented exercise training on fatigue, sleep and quality of life during the postoperative radiotherapy period of breast cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600124261
Enrollment
Unknown
Registered
2026-05-09
Start date
2026-03-12
Completion date
Unknown
Last updated
2026-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Group A (standard-dose combined exercise):Aerobic training: 5 days a week, 30 minutes each time (including warm-up/cool-down), target intensity RPE 11–13
Resistance training: 2 times a week, approximately 30 minutes each time, 8 fixed exercises (sitting-to-standing, step pedaling, seated rowing, standing bench press, external rotation of shoulders, ant
Full supervision during hospital radiotherapy period, online (check-in) + weekly follow-up supervision after discharge
Total intervention period 12 weeks.
Group B (Fragmented Equal-Dose Comprehensive Exercise):Aerobic training: 5 days a week, 3 times a day for 10 minutes each (with an interval of = 2 hours), total weekly minutes are equal to those of Gr
Target intensity: RPE 11–13
Resistance training: 6 times a week, each session lasts approximately 10 minutes, consisting of a micro-training unit of 3 movements (2 sets of each × 10–12 repetitions), cycling through units A/B/C,
The rest of the supervision and follow-up are the same as Group A
The total intervention period is 12 weeks.
Group B (Control):Receive the conventional radiotherapy care pathway and health education, without providing structured prescription-based exercise training and supervision
for ethical considerations, general exercise safety education can be provided.

Sponsors

Nanping First Hospital Affiliated to Fujian Medical University (Nanping First Hospital)
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. Female, aged 18 to 75 years. 2. Pathologically confirmed breast cancer, having undergone surgery (breast-conserving surgery or modified radical mastectomy, etc.), and planning to receive adjuvant radiotherapy. 3. Baseline assessment can be completed and written informed consent can be signed before the start of radiotherapy. 4. ECOG 0-2, stable vital signs. 5. No contraindications to moderate-intensity exercise as assessed by the attending physician. 6. Able to understand and follow training instructions.

Exclusion criteria

Exclusion criteria: 1. Distant metastasis or need for urgent other anti-tumor treatmen. 2. Unstable cardiovascular/respiratory system diseases or other contraindications to exercise. 3. Resting blood pressure >= 180/110 mmHg or severe arrhythmia. 4. Severe hematological abnormalities or acute infection/fever (>= 38.0 deg C). 5. Current severe stage of breast cancer-related lymphedema (BCRL) or acute upper limb inflammation. 6. Severe cognitive/mental disorders that prevent cooperation. 7. The investigator deems the participant unsuitable for participation.

Design outcomes

Primary

MeasureTime frame
Cancer-related fatigue;

Secondary

MeasureTime frame
Sleep quality ;Upper limb function;Radiation dermatitis;Quality of Life ;physical activity;Compliance and Time Burden;Adverse event;

Countries

China

Contacts

Public ContactQiandi Huang

Nanping First Hospital Affiliated to Fujian Medical University (Nanping First Hospital)

583508876@qq.com+86 599 863 8275

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: May 16, 2026